By Cecilia Butini
Novartis AG on Wednesday posted decrease gross sales and revenue because it took a success from generic medicines competitors and better restructuring prices, however elevated its dividend for 2022.
The Swiss pharma main posted internet revenue of $1.47 billion, down from $16.31 billion the yr prior, when it benefited from the sale of its funding…
Source web site: www.marketwatch.com
